Aiping
Aiping Cheng, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20090318514 | Novel Pharmaceutical Compositions - The invention provides the use of compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, for the manufacture of a medicament for the treatment or prophylaxis of a condition that may be treated with a thyroid receptor agonist or partial agonist wherein R | 12-24-2009 |
20100004271 | HETEROCYCLIC COMPOUNDS AS AGANIST FOR THE THYROID RECEPTOR - The invention provides Compounds of formula (I) or pharmaceutically acceptable esters, amides, solvates or salts thereof, including salts of such esters or amides, and solvates of such esters, amides or salts, wherein R | 01-07-2010 |
20110190294 | NOVEL ESTROGEN RECEPTOR LIGANDS - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, and a solvate of such an ester, amide, carbamate or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity, wherein R | 08-04-2011 |
20110201555 | NOVEL ESTROGEN RECEPTOR LIGANDS - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. | 08-18-2011 |
20120202861 | NOVEL ESTROGEN RECEPTOR LIGANDS - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt. The invention also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity. Formula (I) wherein R | 08-09-2012 |
20130131061 | Novel Estrogen Receptor Ligands - The invention provides a compound of formula (I) or a pharmaceutically acceptable ester, amide, carbamate, solvate or salt thereof, including a salt of such an ester, amide or carbamate, and a solvate of such an ester, amide, carbamate or salt. The invention also provides also provides the use of such compounds in the treatment or prophylaxis of a condition associated with a disease or disorder associated with estrogen receptor activity, wherein R | 05-23-2013 |
20140323518 | NOVEL ESTROGEN RECEPTOR LIGANDS - Compounds of formula (I) or a pharmaceutically acceptable ester, amide, carbamate or salt thereof, including a salt of such an ester, amide or carbamate in which R | 10-30-2014 |
Aiping Feng, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20150190863 | Control Method and Apparatus for Continuous Casting Steel Pouring - The present invention discloses a control method for continuous casting steel pouring, wherein: Step one: measuring and reading a steel ladle pouring position signal by a steel ladle position sensor ( | 07-09-2015 |
Aiping Lu, Yunnan CN
Patent application number | Description | Published |
---|---|---|
20140187801 | ASYMETRIC SYNTHESIS OF NORCANTHARIDIN ANALOUGUS BY ALKYNYLATION OF OXABENZONORBORNADIENES AND THEIR ANTICANCER ACTIVITIES - The present invention relates to a type of norcantharidin analogues and a method to synthesis such norcantharidin analogues by transition metal-catalyzed alkynylation of 7-oxabenzonorbornadienes. The present invention also relates to the use of such norcantharidin analogues in manufacture of a medicament for the treatment of cancer tumors. | 07-03-2014 |
Aiping Lu, Hk HK
Patent application number | Description | Published |
---|---|---|
20140194499 | Polyprenylated Benzoylphloroglucinols With Anticancer Activity - Two novel polyprenylated benzoylphloroglucinol derivatives, garciesculentones A and C, are disclosed in the present invention. Garciesculentones A and C exhibit cytotoxicity and/or antimigration effect against various cancer cell lines. The experimental results of the present invention suggest that Garciesculentones A and C are useful for developing into anticancer drugs. | 07-10-2014 |
20140194529 | USAGE OF NATURAL COMPOUND FOR TREATING INFLAMMATION AND CANCER - This invention relates to the use of a compound from natural sources for therapeutic uses. More particularly, it relates to a compound, Garcimultiflorone E, naturally occurring in the plant of | 07-10-2014 |
20150038569 | Anti-cervical Cancer Compound and Method of Use Thereof - Cervical cancer is one of the most common malignancies and is associated with a dismal prognosis. The most common therapeutic option for cervical cancer consists of surgery in early stages, and chemotherapy or radiotherapy in more advanced stages of the disease. Although treatment options have increased for some patients, overall progress has been modest. This invention relates to a method for treating cancer comprising administering an anti-cancer compound. More particularly, the present invention relates to an anti-cervical-cancer compound for treating human cervical cancer and tumor. | 02-05-2015 |
Aiping Lu, Kowloon Tong HK
Patent application number | Description | Published |
---|---|---|
20140348965 | USE OF A FLAVANOL GLYCOSIDE FOR SUPPRESSING ACTIVATION OF STELLATE CELLS - A method for suppressing activation of pancreatic stellate cells of a subject includes administering a composition comprising a therapeutically effective amount of Eruberin A. A method of preventing, alleviating or treating pancreatic tumors or pancreatic tumors related diseases includes administering a composition comprising a therapeutically effective amount of Eruberin A. The Eruberin A may be extracted from | 11-27-2014 |
Aiping Lu, Kowloon HK
Patent application number | Description | Published |
---|---|---|
20150079128 | CHINESE MEDICINAL FORMULATION FOR TREATING INFLAMMATORY BOWEL DISEASE AND THE PREPARATION THEREOF - This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian). | 03-19-2015 |
Aiping Wang, Changzhou CN
Patent application number | Description | Published |
---|---|---|
20120116400 | FIXATION DEVICE FOR INTRAMEDULLARY NAIL - A fixation device for an intramedullary nail for proximal femoral fractures, including a main intramedullary nail, a combined locking nail, and cortical bone screws. The main intramedullary nail has a longitudinal axis, a proximal end, and a distal end with a tip. The proximal end includes a through hole for assembling the combined locking nail. The distal end includes an oblong through hole and a circular through hole, both for receiving the cortical bone screws. The combined locking nail includes a head, a distal end of the locking nail, a sleeve, a connecting block, and a cover cap. The connecting block includes a left-handed external thread. The cover cap includes a left-handed internal thread matching with the external thread of the connecting block, a symmetrical sliding plane, and a protrusion block disposed at the end of the symmetrical sliding plane. | 05-10-2012 |
Aiping Wang, Yantai CN
Patent application number | Description | Published |
---|---|---|
20140377369 | COMPOSITIONS OF ROTIGOTINE, DERIVATIVES THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS OF ROTIGOTINE OR ITS DERIVATIVES - The disclosure relates to a composition comprising rotigotine or a pharmaceutically acceptable salt thereof; at least one poly(lactide-co-glycolide) (PLGA); and at least one fatty acid, wherein the at least one fatty acid is at least 0.5% in weight relative to the total weight of the composition. The composition as disclosed herein has significantly reduced burse release effect. The disclosure also provides a method of treating Parkinson's disease comprising administering an effective amount of the composition as disclosed to a subject in need thereof. | 12-25-2014 |
Aiping Wu, Beijing CN
Patent application number | Description | Published |
---|---|---|
20130176014 | MULTI-LEVEL VOLTAGE CONVERTER - The invention discloses a voltage source converter and a voltage source converter system. The voltage source converter comprises: a multi-level voltage source converter, being adapted to output a multiple levels of a first voltage at one of two first output terminals through a multiple of first conducting paths; a first energy store; and a first switching element, being arranged to directly connected with the first output terminal, and being adapted to switch the first energy store in or out of the first conducting path so as to combine a level of the voltage of the first energy store with the level of the first voltage as a second voltage output at a second output terminal. By having the topology as above, the voltage class of each of the power semiconductors can be kept lower with the number of the power semiconductors unchanged. Besides, V | 07-11-2013 |
Aiping Xie, Jinan City CN
Patent application number | Description | Published |
---|---|---|
20120289699 | Process for Preparing and Purifying Bortezomib - The present invention provides a synthetic process for producing bortezomib using a novel intermediate. The present invention also provides a process for purifying bortezomib anhydride, and a new crystalline polymorph of bortezomib anhydride. | 11-15-2012 |
Aiping Xu, Shenzhen CN
Patent application number | Description | Published |
---|---|---|
20140209586 | PORTABLE IGBT ARC WELDING MACHINE - A portable IGBT (Insulated Gate Bipolar Transistor) of high reliability, compact size, and low cost includes a main circuit to which a control circuit and an auxiliary power supply circuit are connected. The main circuit includes, in sequence, an input rectifier filter circuit, an inverter circuit, a high-frequency primary transformer, and a secondary output rectifier circuit. The control circuit includes a PWM regulation circuit, an IGBT driving circuit, a current feedback circuit, and a current setup circuit. The inverter circuit includes a full-bridge hard switching structure, which has IGBTs constituting bridge arms that are sequentially conducted, so that their alternating conduction converts direct current into high frequency square wave alternating current, which flows through the high-frequency primary transformer and is then subjected to rectification to supply an output of low voltage direct current. Each IGBT is connected in parallel to resistor and capacitor, which constitute a peak voltage absorption circuitry. | 07-31-2014 |
Aiping Yu, Waterloon2l 3g1 CA
Patent application number | Description | Published |
---|---|---|
20150376013 | METHOD FOR PRODUCING FEW-LAYER GRAPHENE - A method of producing single or few-layer graphene comprises exfoliating graphite with a polymer to form a graphene-polymer composite and subsequently treating the composite to disassociate graphene. The exfoliation process is conducted using sonication. The graphene is disassociated from the polymer by a treatment step such as acid hydrolysis. The method results in highly pure graphene. | 12-31-2015 |
Aiping Yu US
Patent application number | Description | Published |
---|---|---|
20150141666 | Low Cost Synthesis of Single Material Bifunctional Nonprecious Catalyst for Electrochemical Devices - A bifunctional catalyst for catalyzing both an oxygen reduction reaction and an oxygen evolution reaction is provided, wherein the catalyst comprises a doped graphene backbone having thiol functional groups. A method for producing a bifunctional catalyst is also provided. | 05-21-2015 |